Compare ORA & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ORA | CAI |
|---|---|---|
| Founded | 1965 | 2008 |
| Country | United States | United States |
| Employees | 1512 | N/A |
| Industry | Electric Utilities: Central | Medical Specialities |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9B | 7.6B |
| IPO Year | 2004 | 2025 |
| Metric | ORA | CAI |
|---|---|---|
| Price | $113.55 | $26.79 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 7 |
| Target Price | ★ $114.25 | $34.43 |
| AVG Volume (30 Days) | 553.2K | ★ 2.5M |
| Earning Date | 11-03-2025 | 11-05-2025 |
| Dividend Yield | ★ 0.42% | N/A |
| EPS Growth | ★ 11.26 | N/A |
| EPS | ★ 2.18 | N/A |
| Revenue | ★ $944,248,000.00 | $649,062,000.00 |
| Revenue This Year | $11.57 | $77.69 |
| Revenue Next Year | $17.18 | $35.80 |
| P/E Ratio | $52.02 | ★ N/A |
| Revenue Growth | 6.07 | ★ 112.02 |
| 52 Week Low | $61.58 | $22.86 |
| 52 Week High | $116.66 | $42.50 |
| Indicator | ORA | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 57.96 | N/A |
| Support Level | $109.80 | N/A |
| Resistance Level | $116.66 | N/A |
| Average True Range (ATR) | 2.46 | 0.00 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 55.51 | 0.00 |
Ormat Technologies Inc is engaged in the geothermal and recovered energy power business. It is engaged in three business segments: Electricity Segment. where the company develops, builds, owns and operates geothermal, solar PV and recovered energy-based power plants in the United States and geothermal power plants in other countries and sell the electricity generated. Product Segment includes designing, manufacturing and selling equipment for geothermal and recovered energy-based electricity generation and providing services relating to the engineering, procurement and construction of geothermal and recovered energy-based power plants. Energy Storage Segment includes owning and operating grid-connected which provide capacity, energy and ancillary services directly to the electric grid.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.